SCHEMBL7422251

SCHEMBL7422251

CCc1c(CC=C2C(=O)Nc3ccccc32)[nH]c(C)c1C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 4/20 0.67
ALK Q9UM73 5/20 0.50
KDR P35968 7/20 0.47
RET P07949 5/20 0.46
FGFR1 P11362 5/20 0.46
FLT3 P36888 5/20 0.46
FLT1 P17948 4/20 0.46
AURKA O14965 3/20 0.46
MAP4K2 Q12851 3/20 0.46
STK3 Q13188 3/20 0.46
AURKB Q96GD4 3/20 0.46
CSF1R P07333 3/20 0.46
FGFR3 P22607 3/20 0.46
FLT4 P35916 3/20 0.46
ZAP70 P43403 2/20 0.46
ABL1 P00519 2/20 0.46
PLK4 O00444 2/20 0.46
PDPK1 O15530 2/20 0.46
JAK2 O60674 2/20 0.46
PRKD3 O94806 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7428873 0.85 PDGFRB (0.52) PDGFRBALKKDRRETFGFR1
SCHEMBL6000845 0.80 PDGFRB (1.00) PDGFRBALKKDRRETFGFR1
SCHEMBL6000848 0.80 PDGFRB (1.00) PDGFRBALKKDRRETFGFR1
SCHEMBL7420844 0.80 KDR (0.58) PDGFRBALKKDRRETFGFR1
SCHEMBL20338611 0.78 FGFR1 (0.70) PDGFRBALKKDRRETFGFR1
SCHEMBL7421627 0.76 KDR (0.48) PDGFRBALKKDRRETFGFR1
SCHEMBL5728018 0.75 PDGFRB (0.81) PDGFRBALKKDRRETFGFR1
SCHEMBL5728020 0.75 PDGFRB (0.81) PDGFRBALKKDRRETFGFR1
SCHEMBL1444503 0.71 MAPT (0.54) PDGFRBALKKDRRETFLT3
SCHEMBL1444136 0.71 MAPT (0.54) PDGFRBALKKDRRETFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0769947-A4 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN INC (US) 1998-09-30 EP disclosed
EP-0769947-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE Sugen, Inc. (US) 1997-05-02 EP disclosed
WO-1996040116-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN, INC. (US) 1996-12-19 WO disclosed